Summary
A short survey on the sphingolipid storage diseases is presented. The chemical nature of the accumulated substances is related to the genetically induced enzymic blocks in their biodegradation. Two disorders are stressed which alter the nervous system: metachromatic leukodystrophy and familiar infantile amaurotic idiocy (GM2-gangliosidosis). The difficulties in the causal interpretation of three variants of the latter disease due to the involvement of isoenzymes are dealt with. The relationship between the enzyme defect in these disorders and their time of clinical onset is discussed. Finally, the diagnostic possibilities are presented which are a prerequisite for preventing a further dissemination of these therapy-resistent inborn errors of metabolism.
Zusammenfassung
Es wird ein kurzer Überblick über die Sphingolipidspeicherkrankheiten gegeben. Die chemische Natur der gespeicherten Substanzen und die Ursache ihrer Speicherung durch einen genetisch bedingten Defekt im abbauenden Enzymsystem wird dargelegt. Der Schwerpunkt liegt auf zwei Sphingolipidosen, die das Nervensystem alterieren, der metachromatischen Leukodystrophie und familiären infantilen amaurotischen Idiotie (GM2-Gangliosidose). Die Komplikation in der Deutung der Ursache von 3 Varianten der GM2-Gangliosidose durch Isoenzyme wird behandelt. Die Beziehungen zwischen Enzymdefekt und Erkrankungsbeginn werden diskutiert und schließlich die Diagnosemöglichkeiten als Hilfsmittel zur Verhinderung der weiteren Verbreitung dieser therapieresistenten angeborenen Stoffwechselstörungen angegeben.
Similar content being viewed by others
Literatur
Beutler, E., Kuhl, W.: Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isoenzymes. Nature 258, 262–264 (1975)
Beutler, E., Kuhl, W., Comings, D.: Hexosaminidase isoenzyme in Type O GM2-Gangliosidosis (Sandhoff-Jatzkewitz Disease). Am. J. Human Genet. 27, 628–638 (1975)
Callahan, J. W., Khalil, M., Gerrie, J.: Isoenzymes of sphingomyelinase and the genetic defect in Niemann-Pick disease, Type C. Biochem. Biophys. Res. Commun. 58, 384–390 (1974)
Fischer, G., Jatzkewitz, H.: The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. HoppeSeyler's Z. Physiol. Chem. 356, 605–613 (1975)
Fredrickson, D. S., Sloan, H. R.: Sphingomyelin lipidoses: Niemann-Pick disease. In: The metabolic basis of inherited disease (Eds. Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S.), 3. Aufl. McGraw-Hill, New York, 783–807 (1972)
Galjaard, H., Hoogeveen, A., de Wit-Verbeek, H.A., Reuser, A. J. J., Keijzer, W., Westerveld, A., Bootsma, D.: Tay-Sachs and Sandhoffs disease: Intergenic complementation after somatic cell hybridization. Exptl. Cell Res. 87, 444–448 (1974)
Hers, H. G.: Inborn lysosomal diseases. Gastroenterology 48, 625–633 (1965)
Jatzkewitz, H.: Zerebrale Sphingolipidosen als angeborene Stoffwechselstörungen. Dtsch. med. Wschr. 95, 131–139 (1970)
Jatzkewitz, H., Mehl, E.: Cerebroside-sulphatase and aryl-sulphatase A deficiency in metachromatic leukodystrophy (ML). J. Neurochem. 16, 19–28 (1969)
Jatzkewitz, H., Stinshoff, K.: An activator of cerebroside sulphatase in human normal liver and in cases of congenital metachromatic leukodystrophy. FEBS Letters 32, 129–131 (1973)
Porter, M. T., Fluharty, A. L., Trammell, J., Kihara, H.: A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem. Biophys. Res. Commun. 44, 660–666 (1971)
Pilz, H.: Late adult metachromatic leukodystrophy: aryl-sulphatase A activity of leukocytes in two families. Arch. Neurol. 27, 87–90 (1972)
Pilz, H., Hopf, H. C.: A preclinical case of late adult metachromatic leukodystrophy?; manifestation only with lipid abnormalities in urine, enzyme deficiency, and decrease of nerve conduction velocity. J. Neurol. Neurosurg. Psychiat. 35, 360–364 (1972)
Sandhoff, K., Harzer, K., Wässle, W., Jatzkewitz, H.: Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J. Neurochem. 18, 2469–2489 (1971)
Sandhoff, K., Wässle, W.: Anreicherung und Charakterisierung zweier Formen der menschlichen N-Acetyl-ß-D-hexosaminidase. Hoppe-Seyler's Z. Physiol. Chem. 352, 1119–1133 (1971)
Sandhoff, K., Jatzkewitz, H.: The chemical pathology of Tay-Sachs disease. In: Sphingolipids, Sphingolipidoses and Allied Disorders. (Eds. Volk, B. W., Aronson, S. M.), Plenum Publishing Co., New York, 305–320 (1972)
Sandhoff, K.: Multiple human hexosaminidases. Birth Defects (Original Article Series, No. IX) 214–222 (1973)
Sandhoff, K.: Sphingolipidoses. J. clin. Path. 27, Suppl. (Roy. Coll. Path.), 8, 94–105 (1974)
Sloan, H. R., Fredrickson, D.S.: GM2-Gangliosidoses: Tay-Sachs disease. In: The metabolic basis of inherited disease (Eds. Stanbury, J. B.; Wyngaarden, J. B., Fredrickson, D. S.), 3. Aufl., McGraw-Hill, New York, 615–638 (1972)
Thomas, G. H., Taylor, H.A. Jr., Miller, C. S., Axelman, J., Migeon, B.R.: Genetic complementation after fusion of Tay-Sachs and Sandhoff cells. Nature 250, 580–582 (1974)
Zerfowski, J., Sandhoff, K.: Juvenile GM2-Gangliosidose mit veränderter Substratspezifität der Hexosaminidase A. Acta neuropath. (Berl.) 27, 225–232 (1974)
Author information
Authors and Affiliations
Additional information
Herrn Professor Dr. med. Gerd Peters zu seinem 70. Geburtstag gewidmet.
Rights and permissions
About this article
Cite this article
Jatzkewitz, H., Sandhoff, K. Sphingolipidspeicherkrankheiten als Beispiel einer molekularen Neuropathologie. Arch. F. Psychiatr. U. Z. Neur. 221, 213–225 (1976). https://doi.org/10.1007/BF00418481
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00418481